Schwaig, Germany

Stefan Szelényi

This inventor holds 1 USPTO granted patent. Top assignee: Elbion Ag. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stefan Szelényi. Retrieved from https://idiyas.com/inventor/stefan-szelényi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stefan Szelényi

Introduction

Stefan Szelényi is a notable inventor based in Schwaig, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new compounds with therapeutic potential. His work has led to the creation of innovative solutions that address important medical needs.

Latest Patents

Stefan Szelényi holds a patent for "Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation." This invention relates to new hydroxyindoles of a specific formula, which are utilized as inhibitors of phosphodiesterase 4. The processes for their preparation are also detailed in the patent, showcasing the innovative methods developed by Szelényi.

Career Highlights

Szelényi is associated with Elbion AG, a company focused on advancing pharmaceutical research and development. His role at Elbion AG has allowed him to contribute to groundbreaking research and the development of new therapeutic agents. With a total of 1 patent, his work exemplifies the impact of innovation in the pharmaceutical industry.

Collaborations

Stefan Szelényi has collaborated with notable colleagues, including Norbert Höfgen and Ute Egerland. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to innovative solutions in their field.

Conclusion

Stefan Szelényi's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight the importance of research and development in creating new therapeutic options. His work continues to inspire advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…